OPC Pharmaceutical

OPC

VN000000OPC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 03:30:00 15/05/2024 am IST			5-day change	1st Jan Change
23,950 ^VND	0.00%		-6.08%	-0.21%

02/05	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/01	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

OPC: Thông báo thay đổi số lượng cổ phiếu có quyền biểu quyết đang lưu hành

August 03, 2022 at 04:18 pm IST

03/08/2022 5:21:00 CH

Công ty Cổ phần Dược phẩm OPC thông báo thay đổi số lượng cổ phiếu có quyền biểu quyết đang lưu hành như sau:

Các tập tin đính kèm

20220803_20220803 - OPC - Thay doi so luong co phieu dang lưu hanh.pdf

Attachments

Original Link
Original Document
Permalink

Disclaimer

OPC Pharmaceutical JSC published this content on 03 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2022 10:47:11 UTC.

Latest news about OPC Pharmaceutical

OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	30/01	CI
OPC Pharmaceutical Joint Stock Company Receives the Resignation from Duong Minh Hung as Sales and Marketing Deputy Chief Executive Officer	05/12	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/23/30	CI
OPC Pharmaceutical Joint Stock Company Appoints Mrs. Nguyen Thi Hong the Person in Charge of Corporate Governance Cum Secretary	29/23/29	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31	CI
OPC Pharmaceutical Joint Stock Company Announces the Resignation of Le Van Son as Chairman of the BOD	25/23/25	CI
OPC Pharmaceutical Joint Stock Company Announces the Remaining Cash Dividend in 2023, Payable on May 25, 2023	08/23/08	CI
Opc Pharmaceutical Joint Stock Company Announces Executive Changes	05/23/05	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
OPC Pharmaceutical Joint Stock Company Approves to Pay the First Cash Dividend for 2022, Payment Date: April 26, 2023	30/23/30	CI
OPC Pharmaceutical Joint Stock Company Announces Management Resignations	20/23/20	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	27/23/27	CI
OPC Pharmaceutical Joint Stock Company Appoints Phuong Thanh Nhung as Deputy Chairman of the Board of Director	22/22/22	CI
OPC Pharmaceutical Joint Stock Company Appoints Duong Minh Hung as Deputy CEO	17/22/17	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/22/28	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	27/22/27	CI
OPC Pharmaceutical Joint Stock Company Announces Establishment of the Audit Committee and Risk Management	09/21/09	CI
Opc Pharmaceutical Joint Stock Company Approves First Cash Dividend for 2021, Payable on March 15, 2022	08/21/08	CI
OPC Pharmaceutical Joint Stock Company Elect Members of the Board of Directors and Members of the Board of Supervisors	26/21/26	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21/21/21	CI
Opc Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	22/21/22	CI

Chart OPC Pharmaceutical

Duration

Period

More charts

Company Profile

OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OPC PHARMACEUTICAL	-0.21%	60.28M
ELI LILLY AND COMPANY	+35.01%	709B
NOVO NORDISK A/S	+30.96%	595B
JOHNSON & JOHNSON	-2.60%	367B
MERCK & CO., INC.	+20.83%	334B
ABBVIE INC.	+5.69%	289B
ASTRAZENECA PLC	+14.42%	239B
NOVARTIS AG	+9.41%	211B
ROCHE HOLDING AG	-4.29%	203B
AMGEN INC.	+10.77%	171B

Other Pharmaceuticals

OPC Pharmaceutical

Equities

OPC

VN000000OPC9

Pharmaceuticals

OPC: Thông báo thay đổi số lượng cổ phiếu có quyền biểu quyết đang lưu hành

Latest news about OPC Pharmaceutical

Chart OPC Pharmaceutical

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals